NASDAQ, QDEL - Quidelortho Corp
All references to "we," "our," and "us" in this Annual Report refer to
Quidel Corporation and its subsidiaries.
Overview
We commenced our operations in 1979 and launched our first products,
dipstick-based pregnancy tests, in 1984. Our product base and technology
platforms have expanded through internal development and acquisitions of other
products and technologies. We have a leadership position in the development,
manufacturing and marketing of rapid diagnostic solutions at the professional
point-of-care ("POC") in infectious diseases and reproductive and women's
health. We focus on POC testing solutions specifically developed for the
physician office lab ("POL") and acute care markets globally. We sell our
products to professionals for use in physician offices, hospitals, clinical
laboratories, retail clinics and wellness screening centers. ...
Read SEC Filing on NASDAQ.com »